United States Pharmaceuticals

Teligent Inc (NEW JERSEY) (TLGT)

Track

Track

Ticker: TLGT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Pate R Carter Non-Executive Director
Transaction date
Purchase
Price
110.87
Quantity 97,030 -2.6%
Value US$222,342
CHAUDHURI BHASKAR
Transaction date
Purchase
Price
0.70
Quantity 10,000 +inf%
Value US$7,005
Celentano John E Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 20,000 +inf%
Value US$12,904
GALE JAMES C Non-Executive Director
Transaction date
Purchase
Price
0.66
Quantity 20,000 +5.3%
Value US$13,166
3.5
BEN-MAIMON CAROLE
Transaction date
Purchase
Price
0.59
Quantity 10,000 +166.7%
Value US$5,885
Grenfell-Gardner Jason President & CEO Executive Director
Transaction date
Purchase
Price
0.69
Quantity 25,000 +26.4%
Value US$17,335
GALE JAMES C Non-Executive Director
Transaction date
Purchase
Price
0.69
Quantity 20,000 +5.6%
Value US$13,814
Finio Damian CFO Officer
Transaction date
Purchase
Price
1.82
Quantity 10,000 +inf%
Value US$18,200
Richardson Stephen Chief Scientific Officer Officer
Transaction date
Purchase
Price
1.78
Quantity 12,000 +30.6%
Value US$21,372
Grenfell-Gardner Jason President & CEO Executive Director
Transaction date
Planned sale
Price
4.01
Quantity 100 -0.1%
Value US$400
Grenfell-Gardner Jason President & CEO Executive Director
Transaction date
Planned sale
Price
4.00
Quantity 52,700 -35.7%
Value US$210,800
BEN-MAIMON CAROLE
Transaction date
Purchase
Price
3.48
Quantity 3,600 +150.0%
Value US$12,539
BEN-MAIMON CAROLE
Transaction date
Purchase
Price
3.48
Quantity 1,400 +140.0%
Value US$4,870
KOEHLER STEVEN H
Transaction date
Purchase
Price
3.61
Quantity 300 +6.4%
Value US$1,084
KOEHLER STEVEN H
Transaction date
Purchase
Price
3.62
Quantity 2,900 +161.1%
Value US$10,490
KOEHLER STEVEN H
Transaction date
Purchase
Price
3.62
Quantity 1,800 +inf%
Value US$6,514
GALE JAMES C
Transaction date
Purchase
Price
3.81
Quantity 15,000 +4.4%
Value US$57,136
Richardson Stephen Chief Scientific Officer
Transaction date
Purchase
Price
3.13
Quantity 6,410 +76.9%
Value US$20,056
Collins Jenniffer CFO
Transaction date
Purchase
Price
3.04
Quantity 7,000 +57.3%
Value US$21,280
GALE JAMES C Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.91
Quantity 15,000 +150.0%
Value US$73,718
Grenfell-Gardner Jason President & CEO Executive Director
Transaction date
Purchase
Price
4.82
Quantity 10,500 +4.4%
Value US$50,629
GALE JAMES C Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.04
Quantity 10,000 +25.2%
Value US$50,400
GALE JAMES C Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.04
Quantity 20,000 +101.9%
Value US$100,800
LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
Transaction date
Sale
Price
9.95
Quantity 1,696,320 -16.9%
Value US$16,878,384
LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
Transaction date
Sale
Price
9.95
Quantity 303,680 -16.9%
Value US$3,021,616
LIFE SCIENCES OPPORTUNITIES FUND II LP See Remarks Large shareholder
Transaction date
Sale
Price
6.45
Quantity 1,696,500 -14.4%
Value US$10,942,425
LIFE SCIENCES OPPORTUNITIES FUND II LP See Remarks Large shareholder
Transaction date
Sale
Price
6.45
Quantity 303,500 -14.4%
Value US$1,957,575
LIFE SCIENCES OPPORTUNITIES FUND II LP See Remarks Large shareholder
Transaction date
Sale
Price
6.20
Quantity 2,544,743 -17.8%
Value US$15,777,407
LIFE SCIENCES OPPORTUNITIES FUND II LP See Remarks Large shareholder
Transaction date
Sale
Price
6.20
Quantity 455,257 -17.8%
Value US$2,822,593
GALE JAMES C Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.90
Quantity 5,000 +34.2%
Value US$29,500
Erony Joyce Non-Executive Director
Transaction date
Sale
Price
5.48
Quantity 17,500 -76.6%
Value US$95,900
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 11,902 +19.3%
Value US$17,304
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.48
Quantity 4,000 +6.9%
Value US$5,919
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.48
Quantity 10,000 +21.0%
Value US$14,794
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.48
Quantity 4,508 +10.5%
Value US$6,672
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.49
Quantity 19,590 +83.3%
Value US$29,189
Grenfell-Gardner Jason President & CEO Executive Director
Transaction date
Purchase
Price
1.55
Quantity 3,500 +35.0%
Value US$5,425
GALE JAMES C Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.33
Quantity 10,000 +216.3%
Value US$13,265
Erony Joyce Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.33
Quantity 5,000 +28.0%
Value US$6,647
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 2,100 +9.8%
Value US$2,814
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 900 +4.4%
Value US$1,202
Erony Joyce Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.30
Quantity 12,500 +233.7%
Value US$16,280
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.21
Quantity 3,000 +17.1%
Value US$3,630
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.18
Quantity 468 +2.7%
Value US$552
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.18
Quantity 1,532 +9.9%
Value US$1,808
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 7,639 +96.9%
Value US$8,785
Hemric Michael B. Non-Executive Director
Transaction date
Purchase
Price
1.14
Quantity 4,998 +173.2%
Value US$5,698
Grenfell-Gardner Jason President & CEO Executive Director
Transaction date
Purchase
Price
1.15
Quantity 10,000 +inf%
Value US$11,500
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
0.95
Quantity 7,000 -30.5%
Value US$6,650
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
0.95
Quantity 10,000 -38.6%
Value US$9,500
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.00
Quantity 907 -5.4%
Value US$907
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.00
Quantity 843 -5.0%
Value US$843
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.02
Quantity 300 -1.8%
Value US$306
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.00
Quantity 608 -3.7%
Value US$608
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.00
Quantity 1,485 -8.5%
Value US$1,485
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.05
Quantity 15 -0.1%
Value US$16
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.15
Quantity 8,500 -34.8%
Value US$9,775
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.15
Quantity 4,870 -23.4%
Value US$5,600
Lawrence Nadya Exec. VP-Sales & Marketing Officer
Transaction date
Sale
Price
1.15
Quantity 130 -0.8%
Value US$150
Lawrence Nadya Exec. VP-Sales and Marketing Officer
Transaction date
Sale
Price
1.19
Quantity 25,000 -61.1%
Value US$29,750
Lawrence Nadya Exec. VP-Sales and Marketing Officer
Transaction date
Sale
Price
1.75
Quantity 5,000 -31.4%
Value US$8,750
Lawrence Nadya Exec. VP-Sales and Marketing Officer
Transaction date
Sale
Price
1.60
Quantity 5,000 -31.4%
Value US$8,000
GERARDI FRANK Large shareholder
Transaction date
Purchase
Price
1.28
Quantity 600 +0.0%
Value US$768
GERARDI FRANK Large shareholder
Transaction date
Purchase
Price
1.30
Quantity 500 +0.0%
Value US$650
GERARDI FRANK Large shareholder
Transaction date
Purchase
Price
1.21
Quantity 1,000 +0.0%
Value US$1,210
GERARDI FRANK Large shareholder
Transaction date
Purchase
Price
1.24
Quantity 200 +0.0%
Value US$248
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-27 2021-05-27 B Purchase
3.0
Pate R Carter
Non-Executive Director
97,030 -2.6%
110.87
US$222,342 		97,030 -2.6% 110.87 US$222,342
2020-09-16 2020-08-26 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
72,319 +46.0%
337.30
US$2,841,840 		72,319 +46.0% 337.30 US$2,841,840
2020-09-16 2020-08-26 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
28,731 -12.0%
291.66
US$2,700,505 		28,731 -12.0% 291.66 US$2,700,505
2020-09-16 2020-08-25 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
15,184 -12.9%
1.13
US$17,106 		15,184 -12.9% 1.13 US$17,106
2020-09-16 2020-08-25 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
84,816 -12.9%
1.13
US$96,147 		84,816 -12.9% 1.13 US$96,147
2020-09-16 2020-08-21 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
18,432 -13.5%
1.66
US$30,540 		18,432 -13.5% 1.66 US$30,540
2020-09-16 2020-08-21 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
102,962 -13.5%
1.66
US$171,071 		102,962 -13.5% 1.66 US$171,071
2020-09-16 2020-08-19 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
13,251 -8.9%
2.25
US$29,760 		13,251 -8.9% 2.25 US$29,760
2020-09-16 2020-08-19 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
74,020 -8.9%
2.26
US$167,026 		74,020 -8.9% 2.26 US$167,026
2019-06-04 2019-06-03 B Purchase
CHAUDHURI BHASKAR
10,000 +inf%
0.70
US$7,005 		10,000 +inf% 0.70 US$7,005
2019-06-03 2019-05-31 B Purchase
SABATINO THOMAS J JR
25,000 +inf%
0.66
US$16,520 		25,000 +inf% 0.66 US$16,520
2019-05-31 2019-05-31 B Purchase
Celentano John E
Non-Executive Director
20,000 +inf%
0.65
US$12,904 		20,000 +inf% 0.65 US$12,904
2019-05-31 2019-05-31 B Purchase
GALE JAMES C
Non-Executive Director
20,000 +5.3%
0.66
US$13,166 		20,000 +5.3% 0.66 US$13,166
2019-05-31 2019-05-30 B Purchase
3.5
BEN-MAIMON CAROLE
10,000 +166.7%
0.59
US$5,885 		10,000 +166.7% 0.59 US$5,885
2019-05-24 2019-05-23 B Purchase
Grenfell-Gardner Jason

President & CEO

Executive Director
25,000 +26.4%
0.69
US$17,335 		25,000 +26.4% 0.69 US$17,335
2019-05-24 2019-05-23 B Purchase
GALE JAMES C
Non-Executive Director
20,000 +5.6%
0.69
US$13,814 		20,000 +5.6% 0.69 US$13,814
2018-12-14 2018-12-14 B Purchase Finio Damian

CFO

Officer
10,000 +inf%
1.82
US$18,200 		10,000 +inf% 1.82 US$18,200
2018-12-14 2018-12-14 B Purchase Richardson Stephen

Chief Scientific Officer

Officer
12,000 +30.6%
1.78
US$21,372 		12,000 +30.6% 1.78 US$21,372
2018-09-05 2018-09-04 PlS Planned sale Grenfell-Gardner Jason

President & CEO

Executive Director
100 -0.1%
4.01
US$400 		100 -0.1% 4.01 US$400
2018-09-05 2018-09-04 PlS Planned sale Grenfell-Gardner Jason

President & CEO

Executive Director
52,700 -35.7%
4.00
US$210,800 		52,700 -35.7% 4.00 US$210,800
2017-11-13 2017-11-13 B Purchase BEN-MAIMON CAROLE
3,600 +150.0%
3.48
US$12,539 		3,600 +150.0% 3.48 US$12,539
2017-11-13 2017-11-13 B Purchase BEN-MAIMON CAROLE
1,400 +140.0%
3.48
US$4,870 		1,400 +140.0% 3.48 US$4,870
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
300 +6.4%
3.61
US$1,084 		300 +6.4% 3.61 US$1,084
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
2,900 +161.1%
3.62
US$10,490 		2,900 +161.1% 3.62 US$10,490
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
1,800 +inf%
3.62
US$6,514 		1,800 +inf% 3.62 US$6,514
2017-11-13 2017-11-10 B Purchase GALE JAMES C
15,000 +4.4%
3.81
US$57,136 		15,000 +4.4% 3.81 US$57,136
2017-11-13 2017-11-09 B Purchase Richardson Stephen

Chief Scientific Officer
6,410 +76.9%
3.13
US$20,056 		6,410 +76.9% 3.13 US$20,056
2017-11-09 2017-11-08 B Purchase Collins Jenniffer

CFO
7,000 +57.3%
3.04
US$21,280 		7,000 +57.3% 3.04 US$21,280
2016-03-14 2016-03-11 B Purchase GALE JAMES C Non-Executive Director Large shareholder
15,000 +150.0%
4.91
US$73,718 		15,000 +150.0% 4.91 US$73,718
2016-03-14 2016-03-11 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
10,500 +4.4%
4.82
US$50,629 		10,500 +4.4% 4.82 US$50,629
2015-05-01 2015-04-30 B Purchase GALE JAMES C Non-Executive Director Large shareholder
10,000 +25.2%
5.04
US$50,400 		10,000 +25.2% 5.04 US$50,400
2015-05-01 2015-04-30 B Purchase GALE JAMES C Non-Executive Director Large shareholder
20,000 +101.9%
5.04
US$100,800 		20,000 +101.9% 5.04 US$100,800
2015-03-06 2015-03-05 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
1,696,320 -16.9%
9.95
US$16,878,384 		1,696,320 -16.9% 9.95 US$16,878,384
2015-03-06 2015-03-05 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
303,680 -16.9%
9.95
US$3,021,616 		303,680 -16.9% 9.95 US$3,021,616
2014-09-04 2014-09-02 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
1,696,500 -14.4%
6.45
US$10,942,425 		1,696,500 -14.4% 6.45 US$10,942,425
2014-09-04 2014-09-02 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
303,500 -14.4%
6.45
US$1,957,575 		303,500 -14.4% 6.45 US$1,957,575
2014-08-29 2014-08-27 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
2,544,743 -17.8%
6.20
US$15,777,407 		2,544,743 -17.8% 6.20 US$15,777,407
2014-08-29 2014-08-27 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
455,257 -17.8%
6.20
US$2,822,593 		455,257 -17.8% 6.20 US$2,822,593
2014-08-26 2014-08-22 B Purchase GALE JAMES C Non-Executive Director Large shareholder
5,000 +34.2%
5.90
US$29,500 		5,000 +34.2% 5.90 US$29,500
2014-06-11 2014-06-09 S Sale Erony Joyce Non-Executive Director
17,500 -76.6%
5.48
US$95,900 		17,500 -76.6% 5.48 US$95,900
2013-08-07 2013-08-06 B Purchase Hemric Michael B. Non-Executive Director
11,902 +19.3%
1.45
US$17,304 		11,902 +19.3% 1.45 US$17,304
2013-08-07 2013-08-05 B Purchase Hemric Michael B. Non-Executive Director
4,000 +6.9%
1.48
US$5,919 		4,000 +6.9% 1.48 US$5,919
2013-08-07 2013-08-02 B Purchase Hemric Michael B. Non-Executive Director
10,000 +21.0%
1.48
US$14,794 		10,000 +21.0% 1.48 US$14,794
2013-08-07 2013-07-30 B Purchase Hemric Michael B. Non-Executive Director
4,508 +10.5%
1.48
US$6,672 		4,508 +10.5% 1.48 US$6,672
2013-08-07 2013-07-26 B Purchase Hemric Michael B. Non-Executive Director
19,590 +83.3%
1.49
US$29,189 		19,590 +83.3% 1.49 US$29,189
2013-05-29 2013-05-24 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
3,500 +35.0%
1.55
US$5,425 		3,500 +35.0% 1.55 US$5,425
2013-03-15 2013-03-13 B Purchase GALE JAMES C Non-Executive Director Large shareholder
10,000 +216.3%
1.33
US$13,265 		10,000 +216.3% 1.33 US$13,265
2013-03-14 2013-03-13 B Purchase Erony Joyce Non-Executive Director Large shareholder
5,000 +28.0%
1.33
US$6,647 		5,000 +28.0% 1.33 US$6,647
2013-03-14 2013-03-12 B Purchase Hemric Michael B. Non-Executive Director
2,100 +9.8%
1.34
US$2,814 		2,100 +9.8% 1.34 US$2,814
2013-03-14 2013-03-12 B Purchase Hemric Michael B. Non-Executive Director
900 +4.4%
1.34
US$1,202 		900 +4.4% 1.34 US$1,202
2013-03-14 2013-03-12 B Purchase Erony Joyce Non-Executive Director Large shareholder
12,500 +233.7%
1.30
US$16,280 		12,500 +233.7% 1.30 US$16,280
2013-03-14 2013-03-11 B Purchase Hemric Michael B. Non-Executive Director
3,000 +17.1%
1.21
US$3,630 		3,000 +17.1% 1.21 US$3,630
2013-03-14 2013-03-11 B Purchase Hemric Michael B. Non-Executive Director
468 +2.7%
1.18
US$552 		468 +2.7% 1.18 US$552
2013-03-14 2013-03-08 B Purchase Hemric Michael B. Non-Executive Director
1,532 +9.9%
1.18
US$1,808 		1,532 +9.9% 1.18 US$1,808
2013-03-14 2013-03-07 B Purchase Hemric Michael B. Non-Executive Director
7,639 +96.9%
1.15
US$8,785 		7,639 +96.9% 1.15 US$8,785
2013-03-14 2013-03-06 B Purchase Hemric Michael B. Non-Executive Director
4,998 +173.2%
1.14
US$5,698 		4,998 +173.2% 1.14 US$5,698
2012-08-16 2012-08-14 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
10,000 +inf%
1.15
US$11,500 		10,000 +inf% 1.15 US$11,500
2012-05-30 2012-05-23 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
7,000 -30.5%
0.95
US$6,650 		7,000 -30.5% 0.95 US$6,650
2012-05-30 2012-05-22 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
10,000 -38.6%
0.95
US$9,500 		10,000 -38.6% 0.95 US$9,500
2012-05-30 2012-05-21 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
907 -5.4%
1.00
US$907 		907 -5.4% 1.00 US$907
2012-05-30 2012-05-18 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
843 -5.0%
1.00
US$843 		843 -5.0% 1.00 US$843
2012-05-30 2012-05-17 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
300 -1.8%
1.02
US$306 		300 -1.8% 1.02 US$306
2012-05-30 2012-05-16 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
608 -3.7%
1.00
US$608 		608 -3.7% 1.00 US$608
2012-05-30 2012-05-15 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
1,485 -8.5%
1.00
US$1,485 		1,485 -8.5% 1.00 US$1,485
2012-05-30 2012-05-11 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
15 -0.1%
1.05
US$16 		15 -0.1% 1.05 US$16
2012-03-23 2012-03-19 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
8,500 -34.8%
1.15
US$9,775 		8,500 -34.8% 1.15 US$9,775
2012-03-07 2012-03-01 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
4,870 -23.4%
1.15
US$5,600 		4,870 -23.4% 1.15 US$5,600
2012-03-07 2012-02-28 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
130 -0.8%
1.15
US$150 		130 -0.8% 1.15 US$150
2011-05-13 2011-05-11 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
25,000 -61.1%
1.19
US$29,750 		25,000 -61.1% 1.19 US$29,750
2011-02-04 2011-01-27 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
5,000 -31.4%
1.75
US$8,750 		5,000 -31.4% 1.75 US$8,750
2010-12-08 2010-11-16 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
5,000 -31.4%
1.60
US$8,000 		5,000 -31.4% 1.60 US$8,000
2010-08-11 2010-08-10 B Purchase GERARDI FRANK Large shareholder
600 +0.0%
1.28
US$768 		600 +0.0% 1.28 US$768
2010-08-11 2010-08-10 B Purchase GERARDI FRANK Large shareholder
500 +0.0%
1.30
US$650 		500 +0.0% 1.30 US$650
2010-08-11 2010-08-09 B Purchase GERARDI FRANK Large shareholder
1,000 +0.0%
1.21
US$1,210 		1,000 +0.0% 1.21 US$1,210
2010-08-11 2010-08-09 B Purchase GERARDI FRANK Large shareholder
200 +0.0%
1.24
US$248 		200 +0.0% 1.24 US$248
Explore more

More insider trading research around Teligent Inc (NEW JERSEY)

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America